Colorectal polyp
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)20 y.o. or older 2)Patients with colorectal polyps <= 10mm 3)Patients who gave written informed consent 4)Patients who continued warfarin 5)Patients who continued both warfarin and antiplatelet agent
Exclusion criteria
Exclusion criteria: 1)polyps >10mm 2)Patients with severe comorbidity 3)Patients during pregnancy 4)bleeding tendency except for a drug 5)others
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Delayed bleeding rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Procedural bleeding control rate Procedure related adverse events Rate of residual tumor Incidence of perioperative arterial or venous thromboembolism | — |
Countries
Japan
Contacts
National Hospital Organization Kyushu Medical Center Department of Gastroenterology and Clinical Research Institute